CBIO
CBIO
NASDAQ · Biotechnology

Crescent Biopharma Inc

$12.01
+1.57 (+15.04%)
As of Mar 25, 3:35 PM ET ·
Financial Highlights (FY 2025)
Revenue
57.99M
Net Income
180.8K
Gross Margin
44.8%
Profit Margin
0.3%
Rev Growth
+8.6%
D/E Ratio
0.52
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 44.8% 44.8% 44.8%
Operating Margin 0.5% 0.5% 0.5%
Profit Margin 0.3% 0.4% 0.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 57.99M 51.60M 54.22M
Gross Profit 25.95M 23.10M 24.27M
Operating Income 269.0K 235.0K 268.5K
Net Income 180.8K 210.8K 183.8K
Gross Margin 44.8% 44.8% 44.8%
Operating Margin 0.5% 0.5% 0.5%
Profit Margin 0.3% 0.4% 0.3%
Rev Growth +8.6% +24.1% +21.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 58.46M 55.07M 55.38M
Total Equity 113.09M 116.97M 133.63M
D/E Ratio 0.52 0.47 0.41
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 390.2K 358.0K 370.7K
Free Cash Flow 84.1K 101.4K 117.1K